Aligos Therapeutics, Inc.ALGSNASDAQ
Loading
Year-over-year SG&A expense growth
Percentile
P14
Within normal range
vs 5Y Ago
-0.2x
Contraction
Streak
1 yr
Consecutive growthRecovering
| Period | Value |
|---|---|
| 2025 | -9.25% |
| 2024 | -25.43% |
| 2023 | 15.93% |
| 2022 | -7.42% |
| 2021 | 95.14% |
| 2020 | 46.12% |
| 2019 | 212.17% |
| 2018 | 0.00% |